~8 spots leftby Apr 2026

A Study to Investigate the Safety and Efficacy of a Probiotic on Gastrointestinal Health in Healthy Adults

Recruiting in Palo Alto (17 mi)
DC
Overseen byDavid Crowley, MD
Age: 18 - 65
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: Church & Dwight Company, Inc.

Trial Summary

What is the purpose of this trial?

Eligible participants will be randomized and receive either the probioic or placebo supplement to consume daily for 28-days. Three check-in visits will occur every 7 days of study participation. Participants will be expected to complete a daily study diary documenting their investigational product use/adverse events and a daily bowel habits diary documenting each bowel movement. Blood samples, stool samples, and questionnaires will be completed for study outcome analysis.

Research Team

DC

David Crowley, MD

Principal Investigator

KGK Science Inc.

Eligibility Criteria

Inclusion Criteria

Females and males between 18 to 55 years of age, inclusive
BMI between 18.5 to 32 kg/m2, inclusive
Self-reported history of diarrhea over the last 3 months, defined as > 5 BMs with the majority (≥ 50%) of the BMs per week being Bristol stool form types ≥5, 6 or 7
See 7 more

Treatment Details

Interventions

  • Lactobacillus plantarum 276 (Probiotic)
  • Placebo (Other)
Participant Groups
2Treatment groups
Experimental Treatment
Placebo Group
Group I: ProbioticExperimental Treatment1 Intervention
Group II: PlaceboPlacebo Group1 Intervention

Find a Clinic Near You

Research Locations NearbySelect from list below to view details:
KGK Science Inc.London, Canada
Loading ...

Who Is Running the Clinical Trial?

Church & Dwight Company, Inc.

Lead Sponsor

Trials
27
Patients Recruited
3,300+

KGK Science Inc.

Industry Sponsor

Trials
82
Patients Recruited
6,400+